Skip to main content
. 2014 Aug 6;9:825–836. doi: 10.2147/COPD.S51057

Table 2.

Proposed mechanisms for N-acetylcysteine to reduce exacerbations of chronic obstructive pulmonary disease

Mucolytic effect by reducing viscosity of sputum and secretion in airway
Inhibit attachment of bacteria to epithelium by disrupting bacterial receptor sites on epithelial surface and mucus
Inhibit transmigration of neutrophils by suppressing interleukin-8 and intercellular adhesion molecule-1
Improve small airway function by decreasing epithelial thickening, reducing secretory cell hyperplasia
Reduce lung hyperinflation and reduce emphysema
Reduce lysozyme and lactoferrin concentration
Reduce activation of neutrophils and macrophages
Restore the host innate antiviral response by preventing suppression of oxidant-sensitive retinoic acid inducible gene